UBS analyst Harry Sephton downgraded Sandoz (SDZNY) to Neutral from Buy with a price target of CHF 44, up from CHF 39.50. The firm cites valuation for the downgrade following the stock’s year-to-date rally. It believes Sandoz’s catalyst path in 2025 now well understood.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SDZNY:
- Sandoz price target raised to CHF 41 from CHF 39 at Berenberg
- FDA adds boxed warning to Teva’s Copaxone for allergic reaction
- M&A News: Intra-Cellular Stock Rallies 36% on News of $14.6B Acquisition by Johnson & Johnson
- Intra-Cellular price target raised to $118 from $100 at BofA
- Venu Sports JV discontinued, Walgreens reports Q1 beat: Morning Buzz
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue